Mentor Capital, Inc invests in and acquires cannabis companies both in the medical and social sectors. This publicly traded private equity firm operates by providing smaller companies with passive equity and investing in shelf IPOs. Its aim is to provide founders and small-business owners with public market access.
The company is authorized to bring up USD 23 M from the public market. If a cannabis company wants to obtain public market funding, it may approach Mentor Capital and trade in 10% to 60% of its own business. In turn, Mentor Capital works on delivering higher prices for smaller slices of business, owing to its capital structure and investing approach.
Mentor Capital’s cannabis portfolio includes companies in varied sectors. Namely, these are: Brighter Day Health, GW Pharmaceuticals (having the largest index holding), MicroCannaBiz LLC, Nevada Cannabis Ventures, Shaw Capital Management, Bhang Medicinal Chocolate (agreement currently in dispute), Bhang Financial, and Waste Consolidators, Inc.
The company reaches both the medical and the recreational cannabis sectors, but it has stated that its preferred focus is on the medicine. Among its investments is in the science of cancer immunotheraphy. However, it intends to fully transition to the marijuana industry in time.
Mentor Capital’s long history began in 1985, when it was founded as Main Street Athletic Clubs, a gym company in California. In 2008, it reinvented itself to become Mentor Capital, Inc, with investments in the cancer sector. According to the company, it shifted to the marijuana space when the cancer sector experienced a collapse.
Today, Mentor Capital, Inc is traded as MNTR in the OTC markets. Its market cap is at USD 5.51 M.
Top executives at Mentor Capital include Founder, CEO, and President Chester Billingsley, CFO Lori J. Stansfield, and Director James J. Blazeck.
Mentor Capital, Inc.
P.O. Box 1709
Ramona, CA 92065
Phone: (760) 788-4700
Fax: (760) 788-2525
Yahoo! Finance: MNTR News
Latest Financial News for MNTR
SAN DIEGO, CA / ACCESSWIRE / May 16, 2019 / Mentor Capital, Inc. (OTCQX: MNTR) announced that it had filed its quarterly 10-Q filing for the first quarter ended March 31, 2019, with the Securities and Exchange Commission. The Company reports that for the quarter ended March 31, 2019, Mentor had revenues of $1,075,995 and gross profit of $370,374 with a resulting net loss attributable to Mentor of ($2,406,595) or (10.4 cents) per share. This is a revenue increase from the prior year quarter ended March 31, 2018, in which Mentor had revenues of $1,016,199 and gross profit of $345,707 with a resulting net loss attributable to Mentor of ($151,704) or (0.7 cents) per share.
SAN DIEGO, CA / ACCESSWIRE / March 29, 2019 / Mentor Capital, Inc. (MNTR) announced that it had filed its annual 10-K filing for the year December 31, 2018, with the Securities and Exchange Commission. The Company reports that for the year ended December 31, 2018 Mentor had revenues of $5,281,533 and gross profit of $1,582,599 with a resulting net loss attributable to Mentor of ($409,161) or (1.8 cents) per share. The Mentor Capital, Inc. parent company has no non-affiliate debt and collected a net payment of $1,758,949 on January 23, 2018 in satisfaction of the Company's judgment against Bhang Corporation.
SAN DIEGO, CA / ACCESSWIRE / November 14, 2018 / Mentor Capital, Inc. (MNTR) announced that it had filed its quarterly 10-Q filing for the third quarter ended September 30, 2018, with the Securities and Exchange Commission. For the quarter ended September 30, 2018, Mentor had revenues of $1,031,622 and gross profit of $300,501 with a resulting net income attributable to Mentor of $77,224 or 0.3 cents per share. This is an improvement over the prior year quarter ended September 30, 2017 revenues of $815,102 and gross profit of $289,211, with a resulting net loss attributable to Mentor of ($285,796) or (1.3 cents) per share.
SAN DIEGO, CA / ACCESSWIRE / October 1, 2018 / Mentor Capital, Inc. (OTCQX: MNTR) announced today that it has been invited to present and answer investor questions at the OTCQX® Virtual Investor Conference ...
Mentor Capital, Inc. (MNTR) announced that its investment in G FarmaLabs Limited has increased to $2,700,000 following yesterday’s seventh investment tranche delivered to G Farma of $250,000 from Mentor for additional leased equipment and working capital. Nicole Gonzalez, Founder of G FarmaBrands, comments, “With financial backing from Mentor Capital, G FarmaLabs has hit its benchmarks on the way to building cannabis efficient facilities and production lines.” Ata Gonzalez, Co-Founder of G FarmaLabs concludes, “Chet provides both money and a wealth of knowledge. “Mentor Capital focuses new investment from shareholders and other investors on larger cannabis companies, like G Farma, that have the potential to go public and who may be incubated by Mentor along that path,” explained Mentor Capital, Inc. CEO, Chet Billingsley.